<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="89044">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01914952</url>
  </required_header>
  <id_info>
    <org_study_id>MTI2013-CS02</org_study_id>
    <nct_id>NCT01914952</nct_id>
  </id_info>
  <brief_title>Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses</brief_title>
  <official_title>Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Metabolic Technologies Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Metabolic Technologies Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the rise in plasma  Beta-hydroxy-beta-methylbutyrate
      (HMB) after the dietary supplement has been administered in different forms.  Prior studies
      have indicated that form of administration affects bioavailability of the HMB supplement.
      Therefore the current study will examine the bioavailability of a single dose of HMB given
      as:

        -  1.0g CaHMB in gelatin capsule

        -  0.8 g HMB free acid in a gelcap

        -  0.8 g HMB free acid in water

        -  1.0 g CaHMB in water

        -  0.8 g HMB free acid

      The randomized study will be a crossover design and each study subject will undergo the
      experimental protocol for each of the supplementation forms.  Because of the different
      administration forms, the study will be an open label study.  Briefly, the fasted
      participants will report to the laboratory in the morning.  After an initial blood sample is
      taken, the dose of HMB will be administered.  Blood will then be samples at 2, 5, 10, 15,
      25, 35, 45, 60, 90, 120, 180, 360, 720, and 1440 min post administration.  A 24 h complete
      urine collection will also be performed.  Participants will be given a light sack lunch 4 h
      after administration of the dosage and will remain at the laboratory through the 360 min
      sampling.  Participants will then be allowed to leave the laboratory and return for the 720
      min sampling after which the participants can eat an normal evening meal.  Participants will
      return to the laboratory fasted the next morning for the final sample.  A minimum 48 h
      washout period will be required before the next dosage form is administered and the process
      repeated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Plasma HMB Level</measure>
    <time_frame>Plasma samples collected at 0, 2, 5, 10, 15, 25, 35, 45, 60, 90, 120, 180, 360, 720, and 1440 min after treatment administration</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Focus of the Study is to Examine Plasma HMB Levels After Oral HMB Supplementation</condition>
  <arm_group>
    <arm_group_label>CaHMB Capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB free acid gelcap</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB free acid in water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CaHMB powder in water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB free acid (oral not in gelcap or water)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>CaHMB capsule</intervention_name>
    <description>1.0 gram of CaHMB powder in a gelatin capsule</description>
    <arm_group_label>CaHMB Capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB free acid gelcap</intervention_name>
    <description>0.8 g HMB free acid is a soft gel capsule</description>
    <arm_group_label>HMB free acid gelcap</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB free acid mixed in water</intervention_name>
    <description>0.8 g HMB free acid in water</description>
    <arm_group_label>HMB free acid in water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>CaHMB in water</intervention_name>
    <description>1.0 g CaHMB powder mixed in water</description>
    <arm_group_label>CaHMB powder in water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB free acid</intervention_name>
    <description>0.8 g HMB free acid</description>
    <arm_group_label>HMB free acid (oral not in gelcap or water)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must not be taking amino acid, protein, or HMB supplements; Must not be pregnant;
             Must not be breastfeeding

        Exclusion Criteria:

          -  Currently taking amino acid, protein, or HMB supplements; Currently pregnant;
             Currently breastfeeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rick L Sharp, PhD</last_name>
    <phone>515-294-8650</phone>
    <email>rlsharp@iastate.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Iowa State University</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rick L Sharp, PhD</last_name>
      <phone>515-294-8650</phone>
      <email>rlsharp@iastate.edu</email>
    </contact>
    <investigator>
      <last_name>Rick L Sharp, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 21, 2014</lastchanged_date>
  <firstreceived_date>July 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CaHMB</keyword>
  <keyword>HMB free acid</keyword>
  <keyword>HMB</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
